PCSK9 inhibitor Archives - Baylor College of Medicine Blog Network

Skip to content

Tuesday, June 10, 2025

Latest:

It’s a first: implementing safe and effective RSV prevention treatments significantly reduces hospitalizations in infants
Invisible to the naked eye: Space omics and the need for sample collection guidelines
What are nicotine pouches?
Learning that lifts us all: Insights from a year of growth and professional development
A novel source of genetic variation influencing childhood brain tumors

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol

March 14, 2023 atherosclerosis, bad cholesterol, Cardiovascular Disease, LDL-cholesterol, MK-0616, PCSK9 inhibitor, Research

MK-016 could offer another potential option to achieve guideline-recommended LDL-C levels resulting in reduction of cardiovascular risk.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951